About 4 percent of all advanced cancers—up to 30,000 patients a year in the U.S.—harbor the genetic abnormalities that Keytruda can treat, says Dung Le, oncologist at the Johns Hopkins Bloomberg-Kimmel Institute for Immunotherapy.
…………………………………………………………………………………………………………. यो मुलुक सिंगापुर जस्तो बनिसकेको छैन मात्र राजनीतिक परिवर्तन...